T細胞特異的表面糖タンパク質CD28の世界市場 2020年

• 英文タイトル：Global T Cell Specific Surface Glycoprotein CD28 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201109453 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、T細胞特異的表面糖タンパク質CD28の世界市場を調査対象にし、T細胞特異的表面糖タンパク質CD28の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（FPT-155、FR-104、ルリズマブペゴル、その他）、用途別分析（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Atox Bio Ltd、Johnson & Johnson、Bristol-Myers Squibb Co、Five Prime Therapeutics Inc、TheraMAB LLC ・メーカー別販売量、売上、市場シェア ・T細胞特異的表面糖タンパク質CD28の地域別市場分析 ・T細胞特異的表面糖タンパク質CD28の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・T細胞特異的表面糖タンパク質CD28のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・T細胞特異的表面糖タンパク質CD28のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・T細胞特異的表面糖タンパク質CD28の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・T細胞特異的表面糖タンパク質CD28の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・T細胞特異的表面糖タンパク質CD28の種類別市場規模2015-2020：FPT-155、FR-104、ルリズマブペゴル、その他 ・T細胞特異的表面糖タンパク質CD28の用途別市場規模2015-2020：尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他 ・T細胞特異的表面糖タンパク質CD28の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global T Cell Specific Surface Glycoprotein CD28 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The T Cell Specific Surface Glycoprotein CD28 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
T Cell Specific Surface Glycoprotein CD28 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, T Cell Specific Surface Glycoprotein CD28 market has been segmented into
FPT-155
FR-104
Lulizumab Pegol
Others

By Application, T Cell Specific Surface Glycoprotein CD28 has been segmented into:
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global T Cell Specific Surface Glycoprotein CD28 market presented in the report. This section sheds light on the sales growth of different regional and country-level T Cell Specific Surface Glycoprotein CD28 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global T Cell Specific Surface Glycoprotein CD28 market.

The report offers in-depth assessment of the growth and other aspects of the T Cell Specific Surface Glycoprotein CD28 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and T Cell Specific Surface Glycoprotein CD28 Market Share Analysis
T Cell Specific Surface Glycoprotein CD28 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, T Cell Specific Surface Glycoprotein CD28 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the T Cell Specific Surface Glycoprotein CD28 sales, revenue and market share for each player covered in this report.

The major players covered in T Cell Specific Surface Glycoprotein CD28 are:
Atox Bio Ltd
Johnson & Johnson
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
TheraMAB LLC

Among other players domestic and global, T Cell Specific Surface Glycoprotein CD28 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe T Cell Specific Surface Glycoprotein CD28 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of T Cell Specific Surface Glycoprotein CD28, with price, sales, revenue and global market share of T Cell Specific Surface Glycoprotein CD28 in 2018 and 2019.
Chapter 3, the T Cell Specific Surface Glycoprotein CD28 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the T Cell Specific Surface Glycoprotein CD28 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, T Cell Specific Surface Glycoprotein CD28 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe T Cell Specific Surface Glycoprotein CD28 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 T Cell Specific Surface Glycoprotein CD28 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 FPT-155
1.2.3 FR-104
1.2.4 Lulizumab Pegol
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Plaque Psoriasis
1.3.3 Solid Tumor
1.3.4 Acute Renal Failure(ARF)
1.3.5 Others
1.4 Overview of Global T Cell Specific Surface Glycoprotein CD28 Market
1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Atox Bio Ltd
2.1.1 Atox Bio Ltd Details
2.1.2 Atox Bio Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Atox Bio Ltd SWOT Analysis
2.1.4 Atox Bio Ltd Product and Services
2.1.5 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb Co
2.3.1 Bristol-Myers Squibb Co Details
2.3.2 Bristol-Myers Squibb Co Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb Co SWOT Analysis
2.3.4 Bristol-Myers Squibb Co Product and Services
2.3.5 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Five Prime Therapeutics Inc
2.4.1 Five Prime Therapeutics Inc Details
2.4.2 Five Prime Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Five Prime Therapeutics Inc SWOT Analysis
2.4.4 Five Prime Therapeutics Inc Product and Services
2.4.5 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 TheraMAB LLC
2.5.1 TheraMAB LLC Details
2.5.2 TheraMAB LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 TheraMAB LLC SWOT Analysis
2.5.4 TheraMAB LLC Product and Services
2.5.5 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 T Cell Specific Surface Glycoprotein CD28 Manufacturer Market Share in 2019
3.3.2 Top 6 T Cell Specific Surface Glycoprotein CD28 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Regions
4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Regions (2015-2020)
4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Regions (2015-2020)
4.2 North America T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
4.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
4.5 South America T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Country
5.1.1 North America T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Country (2015-2020)
5.1.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Country (2015-2020)
5.2 United States T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
5.3 Canada T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
5.4 Mexico T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Country
6.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Country (2015-2020)
6.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Country (2015-2020)
6.2 Germany T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
6.3 UK T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
6.4 France T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
6.5 Russia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
6.6 Italy T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Regions (2015-2020)
7.2 China T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7.3 Japan T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7.4 Korea T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7.5 India T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
7.7 Australia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Country
8.1.1 South America T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Country (2015-2020)
8.1.2 South America T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Country (2015-2020)
8.2 Brazil T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
8.3 Argentina T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
9.3 Turkey T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
9.4 Egypt T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
9.5 South Africa T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Type (2015-2020)
10.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2015-2020)
10.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2015-2020)
11 Global T Cell Specific Surface Glycoprotein CD28 Market Segment by Application
11.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
11.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2015-2020)
11.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2015-2020)
12 Market Forecast
12.1 Global T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Growth Rate (2021-2025)
12.2 T Cell Specific Surface Glycoprotein CD28 Market Forecast by Regions (2021-2025)
12.2.1 North America T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025)
12.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025)
12.2.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025)
12.2.4 South America T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025)
12.2.5 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025)
12.3 T Cell Specific Surface Glycoprotein CD28 Market Forecast by Type (2021-2025)
12.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2021-2025)
12.3.2 Global T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Type (2021-2025)
12.4 T Cell Specific Surface Glycoprotein CD28 Market Forecast by Application (2021-2025)
12.4.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Application (2021-2025)
12.4.2 Global T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global T Cell Specific Surface Glycoprotein CD28 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of T Cell Specific Surface Glycoprotein CD28 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global T Cell Specific Surface Glycoprotein CD28 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Atox Bio Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Major Business
Table 9. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Total Revenue (USD Million) (2018-2019)
Table 10. Atox Bio Ltd SWOT Analysis
Table 11. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 12. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Major Business
Table 15. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Total Revenue (USD Million) (2018-2019)
Table 16. Johnson & Johnson SWOT Analysis
Table 17. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 18. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Major Business
Table 21. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Total Revenue (USD Million) (2018-2019)
Table 22. Bristol-Myers Squibb Co SWOT Analysis
Table 23. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 24. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Five Prime Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Major Business
Table 27. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Total Revenue (USD Million) (2018-2019)
Table 28. Five Prime Therapeutics Inc SWOT Analysis
Table 29. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 30. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. TheraMAB LLC Basic Information, Manufacturing Base and Competitors
Table 32. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Major Business
Table 33. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Total Revenue (USD Million) (2018-2019)
Table 34. TheraMAB LLC SWOT Analysis
Table 35. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 36. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global T Cell Specific Surface Glycoprotein CD28 Sales by Regions (2015-2020) (K Pcs)
Table 40. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Regions (2015-2020)
Table 41. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions (2015-2020) (USD Million)
Table 42. North America T Cell Specific Surface Glycoprotein CD28 Sales by Countries (2015-2020) (K Pcs)
Table 43. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries (2015-2020)
Table 44. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Countries (2015-2020) (USD Million)
Table 45. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020)
Table 46. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries (2015-2020)
Table 48. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Regions (2015-2020) (USD Million)
Table 52. South America T Cell Specific Surface Glycoprotein CD28 Sales by Countries (2015-2020) (K Pcs)
Table 53. South America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries (2015-2020)
Table 54. South America T Cell Specific Surface Glycoprotein CD28 Revenue by Countries (2015-2020) (USD Million)
Table 55. South America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020)
Table 60. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 61. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2015-2020)
Table 62. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2015-2020) (USD Million)
Table 63. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2015-2020)
Table 64. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 65. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2015-2020)
Table 66. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Regions (2021-2025)
Table 68. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Type (2021-2025)
Table 70. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Application (2021-2025)
Table 71. Global T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. T Cell Specific Surface Glycoprotein CD28 Picture
Figure 2. Global Sales Market Share of T Cell Specific Surface Glycoprotein CD28 by Type in 2019
Figure 3. FPT-155 Picture
Figure 4. FR-104 Picture
Figure 5. Lulizumab Pegol Picture
Figure 6. Others Picture
Figure 7. T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2018
Figure 8. Plaque Psoriasis Picture
Figure 9. Solid Tumor Picture
Figure 10. Acute Renal Failure(ARF) Picture
Figure 11. Others Picture
Figure 12. Global T Cell Specific Surface Glycoprotein CD28 Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Manufacturer in 2019
Figure 33. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 T Cell Specific Surface Glycoprotein CD28 Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 T Cell Specific Surface Glycoprotein CD28 Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions (2015-2020)
Figure 40. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions in 2018
Figure 41. North America T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
Figure 42. Europe T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
Figure 44. South America T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020)
Figure 46. North America T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries (2015-2020)
Figure 48. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries in 2018
Figure 49. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries in 2018
Figure 51. United States T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020)
Figure 56. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries in 2019
Figure 57. Germany T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Regions 2019
Figure 64. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions 2019
Figure 65. China T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries in 2019
Figure 72. South America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries in 2019
Figure 73. Brazil T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales T Cell Specific Surface Glycoprotein CD28 Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel

---